AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8201739 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 5098
Study 8201739 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 5098
Study 2842680 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2 g of eicosapentaenoic acid per day (treatment group)
Number of subjects: 82
Study 2842680 — intervention group
Group type: COMPARATOR
Intervention: Conventional antiplatelet regimen (325 mg of aspirin and 225 mg of dipyridamole per day; control group)
Number of subjects: 82
Study 29166538 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with 100 μg mL‐1 methylene blue and low power laser (InGaAIP, 660 nm; 100 mW; 40 s)
Number of subjects: 10
Study 29166538 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aPDT)
Number of subjects: 10
Study 28111727 — intervention group
Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil (TAS-102)
Number of subjects: 39
Study 28111727 — intervention group
Group type: COMPARATOR
Intervention: Trifluridine alone
Number of subjects: 39
Study 25893359 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural perineural injection of autologous conditioned serum (ACS) 2.5 to 3 mL
Number of subjects: 40
Study 25893359 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisone (MPS) 2.5 to 3 mL
Number of subjects: 40
Study 23228814 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV)
Number of subjects: 0
Study 21895866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 75
Study 21895866 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 75
Study 18575311 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17177582 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (1 mg/kg every 6 hours, increasing to 1.5 mg/kg if necessary)
Number of subjects: 36
Study 17177582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 17177582 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 36
Study 15794457 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide whitening strips (Crest Whitestrips Premium)
Number of subjects: 39
Study 15794457 — intervention group
Group type: COMPARATOR
Intervention: Placebo strips with no peroxide
Number of subjects: 39
Study 11177057 — intervention group
Group type: EXPERIMENTAL
Intervention: 18‐lesson, 6‐month classroom curriculum to reduce television, videotape, and video game use
Number of subjects: 0
Study 11177057 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9571254 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy plus intravenous cytarabine
Number of subjects: 57
Study 9571254 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy plus intrathecal cytarabine
Number of subjects: 57
Study 9571254 — intervention group
Group type: COMPARATOR
Intervention: Antiretroviral therapy alone
Number of subjects: 57
Study 8169802 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersion formulation under fasting conditions
Number of subjects: 12
Study 8169802 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule formulation under fasting conditions
Number of subjects: 12
Study 8169802 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule formulation with food
Number of subjects: 12
Study 8169802 — intervention group
Group type: COMPARATOR
Intervention: Comparison of capsule formulation with food to without food
Number of subjects: 12
Study 3045780 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable diapers with absorbent gelling material (AGM)
Number of subjects: 0
Study 3045780 — intervention group
Group type: COMPARATOR
Intervention: Conventional disposable diapers
Number of subjects: 0
Study 31277683 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-specific inhibition training (two versions with different Go/NoGo ratios)
Number of subjects: 246
Study 31277683 — intervention group
Group type: COMPARATOR
Intervention: Neutral control training
Number of subjects: 246
Study 31277683 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-specific inhibition training
Number of subjects: 246
Study 27683100 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ALL Intercontinental Berlin‐Frankfurt‐Münster (IC‐BFM) 2002 protocol
Number of subjects: 787
Study 27175448 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea supplements
Number of subjects: 120
Study 27175448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 25012555 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Game Play (Wii Fit Plus™ videogames involving physical exertion)
Number of subjects: 29
Study 25012555 — intervention group
Group type: COMPARATOR
Intervention: Sedentary Game Play (Wii™ videogames played while sitting)
Number of subjects: 29
Study 23272097 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site support (OSS) arm
Number of subjects: 72
Study 23272097 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 72
Study 23272097 — intervention group
Group type: COMPARATOR
Intervention: Comparison of OSS vs Control
Number of subjects: 72
Study 19196748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided IUI (n = 33)
Number of subjects: 73
Study 19196748 — intervention group
Group type: COMPARATOR
Intervention: Clinical IUI (Control group, n = 40)
Number of subjects: 73
Study 19196748 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study 17563128 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram 10-20 mg/day (fixed at 10 mg/day for the first 4 weeks)
Number of subjects: 278
Study 17563128 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine 60 mg/day
Number of subjects: 278
Study 17563128 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 278
Study 17563128 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine
Number of subjects: 278
Study 15728164 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE + MPA (0.625 mg/d of conjugated equine estrogen plus 2.5 mg/d of medroxyprogesterone acetate)
Number of subjects: 23396
Study 15728164 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE (0.625 mg/d of conjugated equine estrogen)
Number of subjects: 23396
Study 15728164 — intervention group
Group type: COMPARATOR
Intervention: Placebo for CEE + MPA
Number of subjects: 23396
Study 15728164 — intervention group
Group type: COMPARATOR
Intervention: Placebo for CEE
Number of subjects: 23396
Study 12496752 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (0.005 mg/kg)
Number of subjects: 11
Study 12496752 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.025 mg/kg)
Number of subjects: 11
Study 12496752 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil plus midazolam
Number of subjects: 11
Study 12496752 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 11
Study 9440475 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro‐Z (200 mg bovine prostate powder supplemented with 20 mg zinc)
Number of subjects: 22
Study 9440475 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 2735479 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training (eight two-hour sessions and one all-day retreat)
Number of subjects: 64
Study 2735479 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 64
Study 2735479 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 64
Study 30643009 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg)
Number of subjects: 100
Study 30643009 — intervention group
Group type: COMPARATOR
Intervention: Meperidine (0.5 mg/kg)
Number of subjects: 100
Study 27497890 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 65
Study 27497890 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 65
Study 24713120 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme on shared decision-making
Number of subjects: 41
Study 24713120 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 41
Study 23877979 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 196
Study 23877979 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and Resistance Training (ATRT)
Number of subjects: 196
Study 23877979 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 196
Study 23877979 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 196
Study 21138455 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g mesalazine once daily (OD)
Number of subjects: 647
Study 21138455 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g mesalazine once daily (OD)
Number of subjects: 647
Study 21138455 — intervention group
Group type: COMPARATOR
Intervention: 0.5 g mesalazine three times daily (t.d.s.)
Number of subjects: 647
Study 18224563 — intervention group
Group type: EXPERIMENTAL
Intervention: Oats-eating coeliac disease patients (n=82)
Number of subjects: 136
Study 18224563 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-oats-eating coeliac disease patients
Number of subjects: 136
Study 18224563 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 136
Study 18224563 — intervention group
Group type: EXPERIMENTAL
Intervention: Oats-eating coeliac disease patients
Number of subjects: 136
Study 16998452 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (450 mg of a‐tocopherol for 8 weeks)
Number of subjects: 20
Study 16998452 — intervention group
Group type: COMPARATOR
Intervention: Placebo (450 mg of lactose for 8 weeks)
Number of subjects: 20
Study 16998452 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 20
Study 12729085 — intervention group
Group type: EXPERIMENTAL
Intervention: Enforce group: feldspathic ceramic inlays luted using Prime & Bond 2.1 and Enforce
Number of subjects: 32
Study 12729085 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX group: inlays cemented with Single Bond and RelyX ARC
Number of subjects: 32
Study 12729085 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin Cement group: ceramic inlays bonded using Single Bond and Resin Cement
Number of subjects: 32
Study 12729085 — intervention group
Group type: COMPARATOR
Intervention: Control group: cavities treated with Single Bond and incrementally filled with a composite resin (P60)
Number of subjects: 32
Study 11051373 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 95
Study 11051373 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 95
Study 11051373 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance strategy every other year and every 6 months for dysplasia
Number of subjects: 95
Study 11051373 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance strategy yearly and every 6 months for dysplasia
Number of subjects: 95
Study 11051373 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental costs of more frequent surveillance
Number of subjects: 95
Study 8834936 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal sinusoidal motion at 0.500 Hz
Number of subjects: 12
Study 8834936 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal sinusoidal motion at 0.350 Hz
Number of subjects: 12
Study 8834936 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal sinusoidal motion at 0.205 Hz
Number of subjects: 12
Study 8834936 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatogravic illusion (SGI) reported by subjects
Number of subjects: 12
Study 1343896 — intervention group
Group type: EXPERIMENTAL
Intervention: Yearly drug therapy for S. haematobium infection
Number of subjects: 0
Study 1343896 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat therapy in years 2 and 3
Number of subjects: 0
Study 1343896 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual therapy re-instituted in 1989 and 1990
Number of subjects: 0
Study 3977334 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% minoxidil solution
Number of subjects: 12
Study 3977334 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% minoxidil solution
Number of subjects: 12
Study 3977334 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% and 5% minoxidil solutions
Number of subjects: 12
Study 31976867 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine with clopidogrel
Number of subjects: 5438
Study 31976867 — intervention group
Group type: COMPARATOR
Intervention: Morphine without clopidogrel
Number of subjects: 5438
Study 28958456 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 120
Study 28958456 — intervention group
Group type: COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Number of subjects: 120
Study 26926477 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversal incision in distal palmar crease
Number of subjects: 30
Study 26926477 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversal incision 2 mm distal from distal palmar crease
Number of subjects: 30
Study 26926477 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal incision over MCP joint without crossing distal palmar crease
Number of subjects: 30
Study 26926477 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 24519386 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 3610
Study 24519386 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 3610
Study 22825889 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (steep axis 0-30°)
Number of subjects: 72
Study 22825889 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (steep axis 31-60°)
Number of subjects: 72
Study 22825889 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (steep axis 61-90°)
Number of subjects: 72
Study 22825889 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 72
Study 20945945 — intervention group
Group type: EXPERIMENTAL
Intervention: LTRA (pranlukast 7 mg/kg bodyweight/day)
Number of subjects: 65
Study 20945945 — intervention group
Group type: COMPARATOR
Intervention: Dietary control group
Number of subjects: 65
Study 18780181 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal intervention (student curriculum and teacher training)
Number of subjects: 5581
Study 18780181 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 5581
Study 18780181 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective intervention (family intervention for high-aggression students)
Number of subjects: 5581
Study 18780181 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention condition
Number of subjects: 5581
Study 15985095 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Leg Club environment
Number of subjects: 33
Study 15985095 — intervention group
Group type: COMPARATOR
Intervention: Home treatment (Control)
Number of subjects: 33
Study 12741304 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 F guide catheters
Number of subjects: 148
Study 12741304 — intervention group
Group type: COMPARATOR
Intervention: 6 F guide catheters
Number of subjects: 148
Study 10870655 — intervention group
Group type: EXPERIMENTAL
Intervention: Adant
Number of subjects: 49
Study 10870655 — intervention group
Group type: COMPARATOR
Intervention: Hyalgan
Number of subjects: 49
Study 10870655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (both Adant and Hyalgan)
Number of subjects: 49
Study 8692118 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. rIL-2 alone
Number of subjects: 215
Study 8692118 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. rIL-2 and rIFN-alpha 2 in combination
Number of subjects: 215
Study 8692118 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. rIL-2, rIFN-alpha 2 and 5-FU
Number of subjects: 215
Study 8692118 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all treatments)
Number of subjects: 215
Study 8692118 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 215
Study 8692118 — intervention group
Group type: EXPERIMENTAL
Intervention: s.c. rIL-2 based protocols
Number of subjects: 215
Study 1526044 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal autoinflation of a toy balloon 3 times daily for 3 weeks
Number of subjects: 40
Study 1526044 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study 6514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fasting (33-50 g protein/day, 1-10 g fat/day, 25-45 g carbohydrates/day, providing 240 to 450 kcal/day)
Number of subjects: 61
Study 6514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fasting
Number of subjects: 61
Study 30905637 — intervention group
Group type: EXPERIMENTAL
Intervention: Crosslinked polyethylene
Number of subjects: 0
Study 30905637 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyethylene
Number of subjects: 0
Study 29701619 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol 88%
Number of subjects: 84
Study 29701619 — intervention group
Group type: COMPARATOR
Intervention: Trichloroacetic Acid 100% (TCA)
Number of subjects: 84
Study 26817454 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intralymphatic immunotherapy (ILIT) with 1000 SQ-U birch- or grass-pollen
Number of subjects: 36
Study 26817454 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intralymphatic immunotherapy (ILIT)
Number of subjects: 36
Study 26817454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 25511777 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with 1000 μg/ml toluidine blue O (TBO) and red LED irradiation applied six times (twice per day) over four days.
Number of subjects: 11
Study 25511777 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with 500 μg/ml TBO and LED irradiation for 20 s.
Number of subjects: 11
Study 25511777 — intervention group
Group type: COMPARATOR
Intervention: Control group (without aPDT).
Number of subjects: 11
Study 22994458 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive migraine intervention (including education, sumatriptan 100 mg, naproxen 500 mg, and expedited headache clinic appointment)
Number of subjects: 50
Study 22994458 — intervention group
Group type: COMPARATOR
Intervention: Typical care (as determined by attending emergency physicians)
Number of subjects: 50
Study 22994458 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive migraine intervention
Number of subjects: 50
Study 22994458 — intervention group
Group type: COMPARATOR
Intervention: Typical care
Number of subjects: 50
Study 20185862 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular autonomic neuropathy (CAN)
Number of subjects: 118
Study 20185862 — intervention group
Group type: COMPARATOR
Intervention: No CAN (control group)
Number of subjects: 118
Study 16973252 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-viscosity glass ionomer (Fuji VII)
Number of subjects: 14
Study 16973252 — intervention group
Group type: COMPARATOR
Intervention: Resin-based glutaraldehyde containing primer (Gluma Desensitizer)
Number of subjects: 14
Study 15782422 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial lozenge
Number of subjects: 138
Study 15782422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study 15782422 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 138
Study 12412686 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP (0.85 kPa (8.5 mbar))
Number of subjects: 16
Study 12412686 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel ventilation (0.85/0.3 kPa (8.5/3 mbar))
Number of subjects: 16
Study 10773793 — intervention group
Group type: EXPERIMENTAL
Intervention: Easyhaler (800 microgram of beclomethasone diproprionate)
Number of subjects: 144
Study 10773793 — intervention group
Group type: COMPARATOR
Intervention: MDI with large-volume spacer (800 microgram of beclomethasone diproprionate)
Number of subjects: 144
Study 10773793 — intervention group
Group type: EXPERIMENTAL
Intervention: Easyhaler
Number of subjects: 144
Study 10773793 — intervention group
Group type: COMPARATOR
Intervention: MDI with large-volume spacer
Number of subjects: 144
Study 10773793 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 144
Study 8726246 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with egg yolk lecithin providing DHA (0.1%) and AA (0.43%)
Number of subjects: 58
Study 8726246 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed infants
Number of subjects: 58
Study 8726246 — intervention group
Group type: COMPARATOR
Intervention: Standard term formula
Number of subjects: 58
Study 8726246 — intervention group
Group type: COMPARATOR
Intervention: Formula with 2% linolenic acid and 0.1% DHA
Number of subjects: 58
Study 1415366 — intervention group
Group type: EXPERIMENTAL
Intervention: Once weekly subcutaneous administration of recombinant human erythropoietin (rHuEPO)
Number of subjects: 0
Study 1415366 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly subcutaneous administration of recombinant human erythropoietin (rHuEPO)
Number of subjects: 0
Study 3933043 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Rehearsal in Same Environment (MRSE)
Number of subjects: 24
Study 3933043 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Rehearsal in Different Environment (MRDE)
Number of subjects: 24
Study 3933043 — intervention group
Group type: COMPARATOR
Intervention: No Mental Rehearsal in Same Environment (NMRSE)
Number of subjects: 24
Study 3933043 — intervention group
Group type: COMPARATOR
Intervention: No Mental Rehearsal in Different Environment (NMRDE)
Number of subjects: 24
Study 31320277 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide plus education
Number of subjects: 300
Study 31320277 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback
Number of subjects: 300
Study 31320277 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide and biofeedback
Number of subjects: 300
Study 31320277 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus education
Number of subjects: 300